Public Citizen Criticizes Dangerous, Flawed FDA Risk-Mitigation Program, Citing Examples of Five Drugs

View as PDF.

In testimony before the Food and Drug Administration (FDA), Public Citizen criticizes the agency’s Risk Evaluation and Mitigation Strategies (REMS) program, citing several areas of failure of the program and noting five drugs that exemplify these failures.